Factors Affecting the Cost Effectiveness of Antibiotics

Table 1

Use of economic evaluation in drug pricing/reimbursement.

Country	Organisation	Implementation date
Australia	Pharmaceutical Benefits Advisory Committee	1993
Belgium	Medicine Reimbursement Committee	2002
England and Wales	National Institute for Health and Clinical Excellence	1999
France	High Health Authority	2008
Germany	Institute for Quality and Efficiency in Health Care	2007
Netherlands	Health Care Insurance Board	1999
New Zealand	Pharmaceutical Management Agency	1993
Scotland	Scottish Medicines Consortium	2002
Sweden	Dental and Pharmaceutical Benefits Agency	2002
Taiwan	Centre for Drug Evaluation	2008